Eden Biodesign expands US operation
Eden Biodesign, a provider of biopharmaceutical process development and cGMP manufacturing services, plans to expand Eden Biodesign Inc, the Group's US subsidiary, with a facility in the biotech hub, Research Triangle Park, North Carolina.
Eden Biodesign, a provider of biopharmaceutical process development and cGMP manufacturing services, plans to expand Eden Biodesign Inc, the Group's US subsidiary, with a facility in the biotech hub, Research Triangle Park, North Carolina.
Eden Biodesign Inc will offer a range of cell line/strain development and early process development services.
"The selection of North Carolina's world-renowned Research Triangle Park signifies the strategic importance of the North American market to Eden Biodesign", said Dr. Crawford Brown, ceo, Eden Biodesign. "By establishing a subsidiary in the United States we are making it easier for clients to access Eden's proven expertise and inspected cGMP manufacturing facilities and confirming Eden's position as a recognised global player in the contract biopharmaceutical manufacturing services market."